77614-64-3

Basic information

• Product Name: 7‐phenyl‐6,8‐dioxaspiro[3.5]nonane‐2,2‐dicarboxylic acid
• Synonyms: 7‐phenyl‐6,8‐dioxaspiro[3.5]nonane‐2,2‐dicarboxylic acid
• CAS NO: 77614-64-3
• Molecular Weight: 292.288
• Mol File: 77614-64-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 7‐phenyl‐6,8‐dioxaspiro[3.5]nonane‐2,2‐dicarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 7‐phenyl‐6,8‐dioxaspiro[3.5]nonane‐2,2‐dicarboxylic acid(77614-64-3)
• EPA Substance Registry System: 7‐phenyl‐6,8‐dioxaspiro[3.5]nonane‐2,2‐dicarboxylic acid(77614-64-3)

Safety Data

• Hazardous Substances Data: 77614-64-3(Hazardous Substances Data)

Upstream product

• 3733-29-7 5,5‐bis(bromomethyl)‐2‐phenyl‐1,3‐dioxane 
• 3296-90-0 bis(bromomethyl)bis(hydroxymethyl)methane 
• 2425-41-4 5,5-dihydroxymethyl-2-phenyl-1,3-dioxane 
• 2209-89-4 (2-phenyl-1,3-dioxane-5,5-diyl)di(methylene) bis(4-methylbenzenesulfonate) 
• 142733-60-6 2,2‐diethyl 7‐phenyl‐6,8‐dioxaspiro[3.5]nonane‐2,2‐dicarboxylate 

Downstream Products

• 4462-97-9 cis-cyclobutane-1,3-dicarboxylic acid anhydride 
• 142733-61-7 cis-1,3-cyclobutanedicarboxylic acid monomethyl ester 
• 2398-16-5 cis-1,3-cyclobutane dicarboxylic acid 
• 7439-33-0 trans-cyclobutane-1,3-dicarboxylic acid 
• 142733-62-8 cis-methyl 3-carboxamidocyclobutanecarboxylate 
• 2398-13-2 trans-1,3-Cyclobutan-dicarbonsaeure-dimethylester 
• 2398-12-1 cis-cyclobutane-dicarboxylic acid-(1.3)-dimethyl ester 
• 2602-14-4 cis-1,3-bis(hydroxymethyl)cyclobutane ditosylate 

Relevant articles and documents

Efficient synthesis of 6-amino-2-thiaspiro[3,3]heptane hydrochloride

A novel compound 6-amino-2-thiaspiro[3,3]heptane hydrochloride was synthesized in nine steps using 2,2-bis(bromomethyl)-1,3-propanediol as starting material, with an overall yield of 31%.

1-(1-CYCLOBUTYL-4-PIPERIDINYL)-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE ML RECEPTOR AND THEIR USE IN MEDICINE

Compounds of formula I or a salt thereof are provided wherein R4, R5, R6, Q, L and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders and cognitive impairments are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.